Effects of a novel selective peroxisome proliferator‐activated receptor‐α modulator, pemafibrate, on hepatic and peripheral glucose uptake in patients with hypertriglyceridemia and insulin resistance

AIMS/INTRODUCTION: Pemafibrate is a novel selective peroxisome proliferator‐activated receptor‐α modulator with potent triglyceride‐lowering and high‐density lipoprotein cholesterol‐raising effects. We showed that pemafibrate decreased the homeostatic model assessment for insulin resistance in patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuba, Ikuro, Matsuba, Ren, Ishibashi, Shun, Yamashita, Shizuya, Arai, Hidenori, Yokote, Koutaro, Suganami, Hideki, Araki, Eiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215940/
https://www.ncbi.nlm.nih.gov/pubmed/29603684
http://dx.doi.org/10.1111/jdi.12845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215940/
https://www.ncbi.nlm.nih.gov/pubmed/29603684
http://dx.doi.org/10.1111/jdi.12845

Ejemplares similares